Source: Annual Congress 2010 - COPD: diagnosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Pertseva, K. Gashynova, N. Efimova (Dnipropetrovsk, Ukraine). COPD: Exhaled NO concentration and its prognostic value for smoking patient. Eur Respir J 2010; 36: Suppl. 54, 4022

Member's Comments

No comment yet.

Related content which might interest you: Smoking and exhaled NO concentration in patients with COPD Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Exhaled breath temperature as a possible early marker in smokers at risk for COPD (MARKO study) Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Exhaled 8-isoprostane as a possible prognostic marker in sarcoidosis Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006 Exhaled NO and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated smoking asthmatics Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Diagnosing asthma and prognostic significance of eNO Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005 The effect of smoking and COPD on exhaled breath temperature Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled breath temperature in COPD patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled NO (eNO) as a screening test for asthma in children Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients. Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020